益气解毒方基于线粒体保护的抗缺血性脑卒中研究(4)
[4]Sachdev PS,Brodaty H,Valenzuela MJ,et al.The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients[J].Neurology,2004,62(6):912-919.
[5]Samsa GP,Matchar DB.How strong is the relationship between functional status and quality of life among persons with stroke?[J].J Rehabil Res Dev,2004,41(3A):279-282.
[6]Streifler JY,Eliasziw M,Benavente OR,et al. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis[J].Stroke,2002,33(6):1651-1655.
[7]Feigin VL,Forouzanfar MH,Krishnamurthi R,et al.Global and regional burden of stroke during 1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2014,383(9913):245-254.
[8]Hankey G J.Stroke[J].Lancet,2016,389(10069):641-654.
[9]Hafez S,Coucha M,Bruno A,et al.Hyperglycemia,acute ischemic stroke,and thrombolytic therapy[J].Transl Stroke Res,2014,5(4):442-453.
[10]Zhao L,Peng F,Guan B,et al.Whether Metal Element-Containing Herbal Formula Angong Niuhuang Pill Is Safe for Acute Brain Disorders?[J].Biol Trace Elem Res,2015,166(1):41-48.
[11]Zhu XL,Xiong LZ,Wang Q,et al.Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats[J].Neurosci Lett,2009,449(1):24-27.
[12]Longa EZ,Weinstein PR,Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
[13]Ballabh P,Braun A,Nedergaard M.The blood-brain barrier: an overview:structure,regulation,and clinical implications[J].Neurobiol Dis,2004,16(1):1-13.
[14]Xia T,Jiang C,Li L,et al.A study on permeability transition pore opening and cytochrome c release from mitochondria, induced by caspase-3 in vitro[J].FEBS Lett,2002,510(1-2):62-66.
[15]朱麗,高健,吴传鸿,等.益气解毒方对大鼠局灶性脑缺血氧化应激的影响[J].中国实验方剂学杂志,2013,19(6):171-173., 百拇医药(杨若聪 田朋朋 吴传鸿 段飞鹏 陈修平 张丽红 闫智勇 李韶菁)
[5]Samsa GP,Matchar DB.How strong is the relationship between functional status and quality of life among persons with stroke?[J].J Rehabil Res Dev,2004,41(3A):279-282.
[6]Streifler JY,Eliasziw M,Benavente OR,et al. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis[J].Stroke,2002,33(6):1651-1655.
[7]Feigin VL,Forouzanfar MH,Krishnamurthi R,et al.Global and regional burden of stroke during 1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2014,383(9913):245-254.
[8]Hankey G J.Stroke[J].Lancet,2016,389(10069):641-654.
[9]Hafez S,Coucha M,Bruno A,et al.Hyperglycemia,acute ischemic stroke,and thrombolytic therapy[J].Transl Stroke Res,2014,5(4):442-453.
[10]Zhao L,Peng F,Guan B,et al.Whether Metal Element-Containing Herbal Formula Angong Niuhuang Pill Is Safe for Acute Brain Disorders?[J].Biol Trace Elem Res,2015,166(1):41-48.
[11]Zhu XL,Xiong LZ,Wang Q,et al.Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats[J].Neurosci Lett,2009,449(1):24-27.
[12]Longa EZ,Weinstein PR,Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
[13]Ballabh P,Braun A,Nedergaard M.The blood-brain barrier: an overview:structure,regulation,and clinical implications[J].Neurobiol Dis,2004,16(1):1-13.
[14]Xia T,Jiang C,Li L,et al.A study on permeability transition pore opening and cytochrome c release from mitochondria, induced by caspase-3 in vitro[J].FEBS Lett,2002,510(1-2):62-66.
[15]朱麗,高健,吴传鸿,等.益气解毒方对大鼠局灶性脑缺血氧化应激的影响[J].中国实验方剂学杂志,2013,19(6):171-173., 百拇医药(杨若聪 田朋朋 吴传鸿 段飞鹏 陈修平 张丽红 闫智勇 李韶菁)